For instance, nicotinamide phosphoribosyl transferase (NAMPT) is a rate-limiting enzyme for mammalian NAD+ synthesis [13,14,15], and NAMPT inhibitors have been shown to reduce NAD+ levels as well as induce cell death in various cancers [16,17,18]. The gene discussed is NAMPT; the disease is cancer.